Hovione and iBET announce strategic collaboration

A strategic partnership that will take Hovione to new technology frontiers.

Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmic

Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction

Hovione Launches ASD-HIPROS

The Most Advanced Screening Service for Optimal Spray Dried Dispersions Formulation

Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury® for COVID-19

Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®

Bilim Pharmaceuticals, H&T Presspart and Hovione Technology unveil collaboration for new asthma product: Ventofor Combi Fix delivered by PowdAir Plus

Hovione Announces the Appointment of Jean-Luc Herbeaux as Chief Operating Officer

Effective May 1st, 2020

Hovione announces successful end-of-phase 2 meeting with the FDA and outlines phase 3 program for minocycline topical gel

Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.

Hovione celebrates its 60th Anniversary in Cork

Loughbeg, Co. Cork. Thursday, September 5th, 2019: Hovione is celebrating its 60th Anniversary today in its site in Cork.

Hovione issues $50 million bond

Hovione has issued a bond of $50 million US dollars maturing in 2033.

Hovione increases production capacity

‘One Site Shop’ expands to respond to growing demands